An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone

Peritoneal Dialysis International

Volumn 23, Issue 5, 2003, Pages 475-480

  Jenkins, Sarah B ^a   Wilkie, Martin E ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Combination; Glucose; Icodextrin; Novel; Peritoneal dialysate; Ultrafiltration

Indexed keywords

EXTRANEAL; GLUCOSE; GLUCOSE POLYMER; ICODEXTRIN; PERITONEAL DIALYSIS FLUID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER SIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; GENERAL HOSPITAL; HUMAN; ISOTOPE DILUTION ASSAY; KIDNEY FAILURE; MALE; OPEN STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; THEORETICAL MODEL; TREATMENT FAILURE; ULTRAFILTRATION; UNITED KINGDOM;

EID: 0142212271     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080302300513     Document Type: Article

References (29)

1. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JGP, Stevens P, et al., for the NECOSAD Study Group. Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. Kidney Int 1999; 55:1476-85.
2. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54:2207-17.
3. Churchill D, Thorpe K, Nolph K, Oreopoulos D, Page D, Keshaviah P. CAPD patient and technique survival are worse with increased membrane permeability [Abstract]. Perit Dial Int 1996; 16(Suppl 2):S21.
4. Wang T, Heimburger O, Waniewski J, Bergström J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13:1242-9.
5. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307-30.
6. Heimbürger O. Residual renal function, peritoneal transport characteristics and dialysis adequacy in peritoneal dialysis. Kidney Int Suppl 1996; 56:S47-55.
7. Raine AEG, Margreiter R, Brunner FP, Ehrich JHH, Geerlings W, Landais P, et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992; 7(Suppl 2):7-35.
8. Lameire N, Vanholder RC, Van Loo A, Lambert MC, Vijt D, Van Bockstaele L, et al. Cardiovascular disease in peritoneal dialysis patients: the size of the problem. Kidney Int Suppl 1996; 56:S28-36.
9. Canada-USA. (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis. Association with clinical outcomes. J Am Soc Nephrol 1996; 7:198-207.
10. Ateş K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
11. Pyle WK, Moncrief JW, Popovich RP. Peritoneal transport evaluation in CAPD. In: Moncrief JW, Popovich RP, eds. CAPD Update. New York: Masson Publishing; 1981:35-52.
12. Stelin G, Rippe B. A phenomenological interpretation of the variation in dialysate volume with dwell time in CAPD. Kidney Int 1990; 38:465-72.
13. Vonesh EF, Lysaght MJ, Moran J, Farrell P. Kinetic modelling as a prescription aid in peritoneal dialysis. Blood Purif 1991; 9:246-70.
14. Rippe B. A three-pore model of peritoneal transport. Perit Dial Int 1993; 13(Suppl 1):S35-8.
15. Vonesh EF, Keshaviah PR. Applications in kinetic modeling using PD Adequest. Perit Dial Int 1997; 17(Suppl 2):S119-25.
16. Rippe B, Levin L. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD. Kidney Int 2000; 57:2546-56.
17. Delarue J, Maingourd C. Acute metabolic effects of dialysis fluids during CAPD. Am J Kidney Dis 2001; 37(Suppl 2):S103-7.
18. Wieslander A, Lindén T. Glucose degradation and cytotoxicity in PD fluids. Perit Dial Int 1996; 16(Suppl 1):S114-18.
19. Dawney A. Advanced glycation end products in peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1):S50-3.
20. Williams JD, Craig KJ, Topley N, von Ruhland C, Fallon M, New GR, et al. Peritoneal Biopsy Study Group. Morphological changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
21. Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 1999; 14: 1541-9.
22. Krediet R, Douma C, Ho-dac-Pannekeet M, Imholz A, Zemel D, Zweers M, et al. Impact of different dialysis solutions on solute and water transport. Perit Dial Int 1997; 17(Suppl 2):S17-26.
23. Bruno M, Bagnis C, Marangella M, Rovera L, Cantaluppi A, Linari F. CAPD with an amino acid dialysis solution: a long term crossover study. Kidney Int 1989; 35:1189-94.
24. Mistry CD, Gokal R. Optimal use of glucose polymer (icodextrin) in peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1):S104-8.
25. Peers EM. Icodextrin plus glucose combinations for use in CAPD. Perit Dial Int 1997; 17(Suppl 2):S68-9.
26. Lindholm B, Heimbürger O, Waniewski J, Werynski A, Bergström J. Peritoneal ultrafiltration and fluid reabsorption during peritoneal dialysis. Nephrol Dial Transplant 1989; 4:805-13.
27. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12:1046-51.
28. Araújo Teixeira MR, Pecoits-Filho RFS, Romao Junior JE, Sabbaga E, Marcondes MM, Abensur H. The relationship between ultrafiltration volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test. Perit Dial Int 2002; 22: 229-33.
29. Brown EA, Davies SJ, Rutherford P, Riegel W, Frandsen NE, Boras M, et al. European APD Outcome Study (EAPOS). Ultrafiltration and not solute clearance or solute transport predicts outcomes at 2 years for APD in anuric patients [Abstract]. J Am Soc Nephrol 2002; 13:1A.